Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-20-139023
Filing Date
2020-05-11
Accepted
2020-05-11 16:05:05
Documents
2
Effectiveness Date
2020-05-11

Document Format Files

Seq Description Document Type Size
1 DEFA14A d930076ddefa14a.htm DEFA14A 65559
2 GRAPHIC g930076g0509081734529.jpg GRAPHIC 5271
  Complete submission text file 0001193125-20-139023.txt   74185
Mailing Address 7575 GATEWAY BOULEVARD SUITE 110 NEWARK CA 94560
Business Address 7575 GATEWAY BOULEVARD SUITE 110 NEWARK CA 94560 510-293-8800
CymaBay Therapeutics, Inc. (Filer) CIK: 0001042074 (see all company filings)

EIN.: 943103561 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-36500 | Film No.: 20864720
SIC: 2834 Pharmaceutical Preparations